{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:57:52Z","timestamp":1761155872600},"reference-count":24,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,6]],"date-time":"2014-11-06T00:00:00Z","timestamp":1415232000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.lpm.2014.07.016","type":"journal-article","created":{"date-parts":[[2014,11,21]],"date-time":"2014-11-21T01:01:05Z","timestamp":1416531665000},"page":"1325-1331","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"P1","title":["Prise en charge de l\u2019hypertension art\u00e9rielle r\u00e9sistante. Consensus d\u2019experts de la Soci\u00e9t\u00e9 fran\u00e7aise d\u2019hypertension art\u00e9rielle, filiale de la Soci\u00e9t\u00e9 fran\u00e7aise de cardiologie"],"prefix":"10.1016","volume":"43","author":[{"given":"Thierry","family":"Denolle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Chamontin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e9rard","family":"Doll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Pierre","family":"Fauvel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Girerd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Herpin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Va\u00efsse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Villeneuve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Michel","family":"Halimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2014.07.016_bib0005","series-title":"Global health risks. Mortality and burden of disease attributable to selected major risks","author":"World Health Organization","year":"2009"},{"key":"10.1016\/j.lpm.2014.07.016_bib0010","first-page":"249","article-title":"Donn\u00e9es sur la mortalit\u00e9 en France\u00a0: principales causes de d\u00e9c\u00e8s en 2008 et \u00e9volutions depuis 2000","volume":"22","author":"Aouba","year":"2011","journal-title":"BEH"},{"key":"10.1016\/j.lpm.2014.07.016_bib0015","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/1741826710394303","article-title":"Patterns of hypertension management in France (ENNS 2006\u20132007)","volume":"19","author":"Godet-Mardirossian","year":"2012","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.lpm.2014.07.016_bib0020","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1161\/HYPERTENSIONAHA.108.189141","article-title":"Resistant hypertension: diagnosis, evaluation, and treatment\u00a0\u2013\u00a0a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research","volume":"51","author":"Calhoun","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.lpm.2014.07.016_bib0025","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/01.hjh.0000431740.32696.cc","article-title":"2013 ESH\/ESC guidelines for the management of arterial hypertension","volume":"31","author":"The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","year":"2013","journal-title":"J Hypertens"},{"key":"10.1016\/j.lpm.2014.07.016_bib0030","first-page":"761","article-title":"Programme r\u00e9gional d\u2019am\u00e9lioration de la prise en charge en m\u00e9decine g\u00e9n\u00e9rale du patient hypertendu","volume":"98","author":"Denolle","year":"2005","journal-title":"Arch Mal Coeur Vaiss"},{"key":"10.1016\/j.lpm.2014.07.016_bib0035","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/HYPERTENSIONAHA.109.131300","article-title":"Triple antihypertensive therapy with amlodipine, valsartan, and hydrochlorothiazide: a randomized clinical trial","volume":"54","author":"Calhoun","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.lpm.2014.07.016_bib0040","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.clinthera.2010.07.008","article-title":"Triple therapy with olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide in adult patients with hypertension: the TRINITY multicenter, randomized, double-blind, 12-week, parallel-group study","volume":"32","author":"Oparil","year":"2010","journal-title":"Clin Ther"},{"key":"10.1016\/j.lpm.2014.07.016_bib0045","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1093\/ajh\/hpt132","article-title":"Prevalence of resistant hypertension and eligibility for catheter-based renal denervation in hypertensive outpatients","volume":"26","author":"Hayek","year":"2013","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.lpm.2014.07.016_bib0050","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ancard.2013.04.011","article-title":"\u00c9volution dans l\u2019usage des traitements antihypertenseurs en France entre 2002 et 2012\u00a0: enqu\u00eates FLASH","volume":"62","author":"Girerd","year":"2013","journal-title":"Ann Cardiol Angeiol"},{"key":"10.1016\/j.lpm.2014.07.016_bib0055","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1161\/HYPERTENSIONAHA.113.01448","article-title":"Prevalence of optimal treatment regimens in patients with apparent treatment-resistant hypertension based on office blood pressure in a community-based practice network","volume":"62","author":"Egan","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.lpm.2014.07.016_bib0060","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jash.2008.12.004","article-title":"Six-item self-administered questionnaires in the waiting room: an aid to explain uncontrolled hypertension in high-risk patients seen in general practice","volume":"3","author":"Mulazzi","year":"2009","journal-title":"J Am Soc Hypertens"},{"key":"10.1016\/j.lpm.2014.07.016_bib0065","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/HJH.0b013e32835e2286","article-title":"Resistant hypertension. Assessment of adherence by toxicological urine analysis","volume":"31","author":"Jung","year":"2013","journal-title":"J Hypertens"},{"key":"10.1016\/j.lpm.2014.07.016_bib0070","series-title":"\u00c9valuation par classes des m\u00e9dicaments antihypertenseurs. Analyse m\u00e9dico-\u00e9conomique","author":"Haute Autorit\u00e9 de sant\u00e9","year":"2012"},{"key":"10.1016\/j.lpm.2014.07.016_bib0075","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1097\/HJH.0b013e32835080b7","article-title":"Depression increases the risk of hypertension incidence: a meta-analysis of prospective cohort studies","volume":"30","author":"Meng","year":"2012","journal-title":"J Hypertens"},{"key":"10.1016\/j.lpm.2014.07.016_bib0080","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1161\/HYPERTENSIONAHA.111.179788","article-title":"Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension","volume":"58","author":"Pedrosa","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.lpm.2014.07.016_bib0085","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1001\/jama.292.19.2343","article-title":"Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events","volume":"292","author":"Okin","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.lpm.2014.07.016_bib0090","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1161\/01.HYP.0000154082.72286.2a","article-title":"Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study","volume":"45","author":"Ibsen","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.lpm.2014.07.016_bib0095","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1097\/HJH.0b013e3283551e98","article-title":"Sequential nephron blockade versus sequential renin\u2013angiotensin system blockade in resistant hypertension: a prospective, randomized, open blinded endpoint study","volume":"30","author":"Bobrie","year":"2012","journal-title":"J Hypertens"},{"key":"10.1016\/j.lpm.2014.07.016_bib0100","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/HYPERTENSIONAHA.111.169961","article-title":"Addition of spironolactone in patients with resistant arterial hypertension (ASPIRANT): a randomized, double-blind, placebo-controlled trial","volume":"57","author":"V\u00e1clav\u00edk","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.lpm.2014.07.016_bib0105","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0140-6736(09)60566-3","article-title":"Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study","volume":"373","author":"Krum","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2014.07.016_bib0110","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(10)62039-9","article-title":"Renal sympathetic denervation in patients with treatment-resistant hypertension (the Symplicity HTN-2 trial): a randomised controlled trial","volume":"376","author":"Esler","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2014.07.016_bib0115","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJMoa1402670","article-title":"A controlled trial of renal denervation for resistant hypertension","volume":"370","author":"Bhatt","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2014.07.016_bib0120","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.acvd.2012.03.005","article-title":"Expert consensus: renal denervation for the treatment of arterial hypertension","volume":"105","author":"Pathak","year":"2012","journal-title":"Arch Cardiovasc Dis"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498214004825?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498214004825?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T15:24:59Z","timestamp":1538061899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498214004825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0755498214004825"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2014.07.016","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prise en charge de l\u2019hypertension art\u00e9rielle r\u00e9sistante. Consensus d\u2019experts de la Soci\u00e9t\u00e9 fran\u00e7aise d\u2019hypertension art\u00e9rielle, filiale de la Soci\u00e9t\u00e9 fran\u00e7aise de cardiologie","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2014.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}